NSC-77625 |
DYRENIUM |
DYTAC |
TRIAMTERENE |
SK-8542 |
NSC-639359 |
SK&F-8542 |
6-PHENYLPTERIDINE-2,4,7-TRIAMINE |
TERIDIN |
TRIAMTEREN |
TRIAMTÉRÈNE |
TRIAMTERENUM |
TRIAMTERENO |
chembl:CHEMBL585 |
rxcui:10763 |
chemidplus:396-01-0 |
drugbank:00384 |
pubchem.compound:5546 |
FDA Approval | 1964 |
Drug Class | small molecule |
Drug Indications | Diuretics |
Drug Indications | Antihypertensive Agents |
Drug Class | antihypertensive agents |
Drug Class | diuretics |
Year of Approval | 1964 |
Drug Categories | sodium channel blockers |
Drug Categories | agents causing hyperkalemia |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | decreased renal k+ excretion |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | increased diuresis |
Drug Categories | nephrotoxic agents |
Drug Categories | photosensitizing agents |
blocker (inhibitory) |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | Amiloride-sensitive sodium channel, ENaC blocker |
blocker (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Amiloride-sensitive sodium channel, ENaC blocker |
Trial Name | - |
blocker (inhibitory) |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | Amiloride-sensitive sodium channel, ENaC blocker |
TRIAMTERENE | DrugBank Drug Name |
396-01-0 | CAS Number |
Apo Triazide | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | agents causing hyperkalemia |
TRIAMTERENE | Primary Drug Name |
Year of Approval | 1964 |
Drug Class | diuretics |
Drug Class | antihypertensive agents |
Drug Indications | Antihypertensive Agents |
Drug Indications | Diuretics |
Drug Class | small molecule |
C29519 | NCI drug code |
D00NKB | TTD Drug ID |
CHEMBL585 | ChEMBL Drug ID |